NRX Pharmaceuticals, Inc. - FORM S-1/A - EX-23.1 - CONSENT OF MARCUM LLP - November 14, 2017

Attached files

file filename
EX-10.8 - PROMISSORY NOTE, DATED AS OF SEPTEMBER 26, 2017, IN FAVOR OF BIG ROCK PARTNERS S - NRX Pharmaceuticals, Inc.brpa_ex108.htm
EX-99.8 - FORM OF NOMINATING COMMITTEE CHARTER - NRX Pharmaceuticals, Inc.brpa_ex998.htm
EX-99.7 - FORM OF COMPENSATION COMMITTEE CHARTER - NRX Pharmaceuticals, Inc.brpa_ex997.htm
EX-99.6 - FORM OF AUDIT COMMITTEE CHARTER - NRX Pharmaceuticals, Inc.brpa_ex996.htm
EX-99.5 - CONSENT OF TROY T. TAYLOR - NRX Pharmaceuticals, Inc.brpa_ex995.htm
EX-99.4 - CONSENT OF ALBERT G. REX - NRX Pharmaceuticals, Inc.brpa_ex994.htm
EX-99.3 - CONSENT OF STUART KOENIG - NRX Pharmaceuticals, Inc.brpa_ex993.htm
EX-99.2 - CONSENT OF MICHAEL FONG - NRX Pharmaceuticals, Inc.brpa_ex992.htm
EX-99.1 - CONSENT OF RICHARD BIRDOFF - NRX Pharmaceuticals, Inc.brpa_ex991.htm
EX-14 - FORM OF CODE OF ETHICS - NRX Pharmaceuticals, Inc.brpa_ex14.htm
EX-10.9 - FORM OF INDEMNIFICATION AGREEMENT FOR OFFICERS, DIRECTORS AND SPECIAL ADVISORS - NRX Pharmaceuticals, Inc.brpa_ex109.htm
EX-10.7 - PROMISSORY NOTE, DATED AS OF SEPTEMBER 26, 2017, IN FAVOR OF RICHARD ACKERMAN - NRX Pharmaceuticals, Inc.brpa_ex107.htm
EX-10.6 - SECURITIES SUBSCRIPTION AGREEMENT, DATED SEPTEMBER 26, 2017, BETWEEN THE REGISTR - NRX Pharmaceuticals, Inc.brpa_ex106.htm
EX-10.5 - FORM OF ADMINISTRATIVE SERVICES AGREEMENT - NRX Pharmaceuticals, Inc.brpa_ex105.htm
EX-10.4 - FORM OF REGISTRATION RIGHTS AGREEMENT AMONG THE REGISTRANT AND THE INITIAL STOCK - NRX Pharmaceuticals, Inc.brpa_ex104.htm
EX-10.3 - FORM OF STOCK ESCROW AGREEMENT BETWEEN THE REGISTRANT, CONTINENTAL STOCK TRANSFE - NRX Pharmaceuticals, Inc.brpa_ex103.htm
EX-10.2 - FORM OF INVESTMENT MANAGEMENT TRUST AGREEMENT BETWEEN CONTINENTAL STOCK TRANSFER - NRX Pharmaceuticals, Inc.brpa_ex102.htm
EX-10.1C - FORM OF LETTER AGREEMENT FOR THE REGISTRANT'S SPONSOR - NRX Pharmaceuticals, Inc.brpa_ex101c.htm
EX-10.1B - FORM OF LETTER AGREEMENT FOR EACH OF THE REGISTRANT'S OTHER OFFICERS AND DIRECTO - NRX Pharmaceuticals, Inc.brpa_ex101b.htm
EX-10.1A - FORM OF LETTER AGREEMENT FOR THE REGISTRANT'S SPONSOR - NRX Pharmaceuticals, Inc.brpa_ex101a.htm
EX-5.1 - OPINION OF AKERMAN LLP - NRX Pharmaceuticals, Inc.brpa_ex51.htm
EX-4.7 - FORM OF UNIT PURCHASE OPTION - NRX Pharmaceuticals, Inc.brpa_ex47.htm
EX-4.6 - FORM OF WARRANT AGREEMENT BETWEEN CONTINENTAL STOCK TRANSFER & TRUST COMPANY AND - NRX Pharmaceuticals, Inc.brpa_ex46.htm
EX-4.5 - FORM OF RIGHT AGREEMENT BETWEEN CONTINENTAL STOCK TRANSFER & TRUST COMPANY AND R - NRX Pharmaceuticals, Inc.brpa_ex45.htm
EX-4.4 - SPECIMEN WARRANT CERTIFICATE - NRX Pharmaceuticals, Inc.brpa_ex44.htm
EX-4.3 - SPECIMEN RIGHT CERTIFICATE - NRX Pharmaceuticals, Inc.brpa_ex43.htm
EX-4.2 - SPECIMEN COMMON STOCK CERTIFICATE - NRX Pharmaceuticals, Inc.brpa_ex42.htm
EX-4.1 - SPECIMEN UNIT CERTIFICATE - NRX Pharmaceuticals, Inc.brpa_ex41.htm
EX-3.4 - ARTICLES OF INCORPORATION / BYLAWS - NRX Pharmaceuticals, Inc.brpa_ex34.htm
EX-3.2 - FORM OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION - NRX Pharmaceuticals, Inc.brpa_ex32.htm
EX-1.2 - LETTER AGREEMENT BETWEEN THE REGISTRANT AND EARLYBIRDCAPITAL - NRX Pharmaceuticals, Inc.brpa_ex12.htm
EX-1.1 - UNDERWRITING AGREEMENT - NRX Pharmaceuticals, Inc.brpa_ex11.htm
S-1/A - REGISTRATION STATEMENT AMENDMENT NO. 1 - NRX Pharmaceuticals, Inc.brpa_s1a.htm
 
 Exhibit 23.1
 
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT
 
We consent to the inclusion in this Registration Statement of Big Rock Partners Acquisition Corp. (the “Company”) on Amendment No. 1 to Form S-1 of our report dated October 13, 2017, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audit of the financial statements of Big Rock Partners Acquisition Corp. as of September 30, 2017 and for the period from September 18, 2017 (inception) through September 30, 2017, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus.
 
/s/ Marcum llp
 
Marcum llp
New York, NY
November 14, 2017
 
 
 
 

NRX Pharmaceuticals, Inc. Reports